WET AMD MODELS

Carefully designed wet Age-Related Macular Degeneration Models.

Age-Related Macular Degeneration (AMD) has a global prevalence of around 170 million. Wet AMD, as opposed to dry AMD, exhibits vascular involvement which greatly exacerbates the pathological process of the disease. Only 10-15% of cases of AMD are wet, and while it is the more severe form, it can be treated.

AMD is one of the world’s top 7 causes of blindness and visual impairment. At PharmaLegacy, we believe that this needs to change. Were we to join efforts, with our models and your pipeline, AMD might one day lose its spot on the world’s leading causes of visual impairment and blindness.

Wet AMD

MODELS / SERVICES

Where pharmacology meets excellence:

  • AAALAC and CNAS guidelines-adherent animal studies
  • 24/7 access to PharmaLegacy representatives
  • Completed over 400 FDA / CFDA IND filings
  • FDA Part 11 compliant

Over half of the top 20 pharmaceutical companies can’t be wrong. Choose PharmaLegacy.

Contact Us

We’re ready when you are.

Tell us your pharmacology challenges.